Related Experiment Videos
Antirheumatic drug reactions in the lung
1Veterans Affairs Medical Center, Salt Lake City, Utah 84148.
Bailliere'S Clinical Rheumatology
|February 1, 1993
Summary
Drug-induced lung disease from antirheumatic drugs requires prompt evaluation. Discontinuing the drug, providing respiratory support, and considering corticosteroids can lead to full recovery.
Area of Science:
- Pulmonology
- Rheumatology
- Clinical Pharmacology
Background:
- Antirheumatic drugs can cause drug-induced lung disease (DILD).
- Pulmonary symptoms in patients on these drugs warrant careful consideration of DILD.
- Early recognition is crucial for effective management.
Purpose of the Study:
- To outline the diagnostic and management approach for DILD in patients treated with antirheumatic drugs.
- To emphasize the importance of timely intervention for optimal patient outcomes.
Main Methods:
- Clinical case review and literature synthesis.
- Diagnostic considerations including exclusion of other pulmonary processes.
- Therapeutic strategies including drug discontinuation, supportive care, and corticosteroid use.
Main Results:
- DILD presents with new pulmonary symptoms in patients on antirheumatic agents.
- Prompt evaluation, discontinuation of offending agents, and supportive care are key.
- Lung biopsy may be necessary for definitive diagnosis.
- Corticosteroids are beneficial in acute pneumonitis.
Conclusions:
- Drug-induced lung disease is a significant concern in patients receiving antirheumatic medications.
- A systematic approach involving prompt diagnosis and treatment can lead to favorable outcomes.
- Early intervention is critical to prevent severe morbidity and mortality.